publication venue for
- Factor XI inhibitors: what should clinicians know. 38:88-93. 2023
- Optimal medical therapy after coronary artery bypass grafting: a primer for surgeons. 36:609-615. 2021
- The role of icosapent ethyl in cardiovascular risk reduction. 36:661-671. 2021
- Genetics of early-onset coronary artery disease. 34:706-713. 2019
- COMPASS for Vascular Surgeons. 34:178-184. 2019
- Individualizing the care of older heart failure patients. 33:208-216. 2018
- Atrial fibrillation occurring transiently with stress. 33:58-65. 2018
- Incorporating patients’ preference diagnosis in implantable cardioverter defibrillator decision-making. 33:42-49. 2018
- Effective approaches to address the global cardiovascular disease burden. 32:557-566. 2017
- Non-infarct related artery revascularization in ST-segment elevation myocardial infarction patients with multivessel disease. 32:600-607. 2017
- P2Y12 receptor inhibitor resistance and coronary artery disease. 32:617-626. 2017
- Anticoagulation for prosthetic heart valves. 31:176-182. 2016
- Heart failure and sleep-disordered breathing. 31:224-228. 2016
- Heart rate and heart failure. 31:204-208. 2016
- Left atrial volume and function in patients with atrial fibrillation. 29:437-444. 2014
- Blood pressure reduction by reducing sodium intake in the population. 29:331-335. 2014
- Myocardial injury after noncardiac surgery. 29:307-311. 2014
- Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation. 29:1-9. 2014
- The aspirin controversy in primary prevention. 27:499-507. 2012
- Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation. 27:331-339. 2012
- Does catheter ablation for atrial fibrillation increase or reduce neurological insult?. 27:36-40. 2012
- Combination therapy for dyslipidemia. 26:420-423. 2011
- Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design. 24:82-87. 2009
- The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality. 23:327-334. 2008
- Right ventricular apical pacing: a necessary evil?. 22:33-38. 2007
- Clinical trials, the renin angiotensin system and atrial fibrillation. 21:368-375. 2006
- Impact of three-dimensional echocardiography in valvular heart disease. 20:122-126. 2005
- Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.. 20:31-37. 2005
- Low molecular weight heparins. 9:612-618. 1994